- Joined
- Dec 2, 2004
- Messages
- 513
- Reaction score
- 1
We just got a contract to help a start up assess their outcomes of their phase ii trial of a treatment with stem cells.
Got me thinking while we were on the conference call (at least I was day-dreaming about something relevant this time) - is there any movement among pharmacists to take hold of this opportunity?
As Z likes to put it, this "chit" is expensive as hell, but I can bet that FDA will eventually roll this into "drug" territory since we're talking doses, ae's, pk and other drug lingo.
Man, all this new tech is fine and dandy, but it's just perpetuating this fugged up game of Jenga we're playing with our top heavy health care system.
Got me thinking while we were on the conference call (at least I was day-dreaming about something relevant this time) - is there any movement among pharmacists to take hold of this opportunity?
As Z likes to put it, this "chit" is expensive as hell, but I can bet that FDA will eventually roll this into "drug" territory since we're talking doses, ae's, pk and other drug lingo.
Man, all this new tech is fine and dandy, but it's just perpetuating this fugged up game of Jenga we're playing with our top heavy health care system.
